Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I like the article and I especially like the coverage in Wellness Magazine that I read all the time. But they never seem to give editing a priority. The title of the article is "Tollovid— An Innovative Treatments For Viruses 881." Treatment needs to be singular not plural and what in the heck is 881.
The newly leased facility in Cleburne, Texas (referenced in 8K/A):
https://www.loopnet.com/Listing/112-E-Industrial-Blvd-Cleburne-TX/25354537/
Amendment 1 to Sec Form 8K filed on Edgar today:
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001645260/000149315222025670/form8-ka.htm
Maybe it's not a big deal, but I wondered why there wasn't any emphasis on the establishment of a "new subsidiary" in the Aug 31 press releases discussing the new leased facility.
It will be interesting to see the approach they take. They are working with West Park Capital https://wpcapital.com/# and I'm sure they'll have some influence on the path taken.
Thanks, looking forward to this facility in full production.
Found this on Gerald's Twitter page:
Media posted by Gerald Commissiong
$TOMDF - manufacturing facility top notch! Started process to make upgrade it cGMP by year end. Team already manufacturing for clients and we expect significant contracts soon as we use Tollovid as the hook to cause clients to buy bulk from us under new sub Todos Botanicals
Twitter · 7 hours ago
There are also some good pictures from the new manufacturing facility but I was unable to copy/paste them...Need help from JFB.
A good discussion of Tollovid, Tollovid Daily, Tollovir, and other 3CL Protease Inhibitor products is found in the video below starting about minute 24:30 with specific comparisons starting at minute 29:00. Note that Tollovid Daily is no longer currently available for purchase.
The primary ingredients in Tollovid and Tollovir are similar. The big difference is that Tollovir has an anti-cytokine agent absent in Tollovid and more of the 3CL Protease inhibition ingredients.
I really don't mean to sound condescending but you've been posing questions that are easily answered if you would spend a little time and review a few of the dozens of videos about Todos that are found on Youtube or look at information for investors on the Todos website. There is a wealth of information available on Todos that is not normally available for a penny stock.
Of course we've tried Tollovid...that is the main reason I invested in Todos. I use it every day and have been using it for quite a while. I have been buying it from mytollovid.com and get discounts like the current 3for3 promotion. Before using mytollovid.com I purchased it from Amazon. My family uses Tollovid and I have given it to numerous friends who have become ill with Covid. Tollovid works!
my order history from mytollovid.com
ORDER DATE PAYMENT STATUS FULFILLMENT STATUS TOTAL
#4132 September 4, 2022 Paid Fulfilled $300.00 USD
#3476 July 4, 2022 Paid Fulfilled $400.00 USD
#3277 June 15, 2022 Paid Fulfilled $119.60 USD
#2986 May 21, 2022 Paid Fulfilled $149.50 USD
#2385 April 5, 2022 Paid Fulfilled $99.00 USD
#2182 February 11, 2022 Paid Fulfilled $448.50 USD
#2024 January 21, 2022 Paid Fulfilled $299.00 USD
#1481 December 16, 2021 Paid Fulfilled $148.50 USD
#1335 December 10, 2021 Paid Fulfilled $99.00 USD
#1333 December 10, 2021 Paid Fulfilled $99.00 USD
#1317 December 6, 2021 Paid Fulfilled $89.10 USD
#1286 November 28, 2021 Paid Fulfilled $84.15 USD
I appreciate your perspective regarding the Todos approach to using influencers. And, their approach may have merit. But, if we step back and ask ourselves the following: what are the demographic groups that stand to gain the most from Tollovid/Tollovir, I think we'd have to primarily focus on the elderly, those who are immune compromised, and those in nursing homes. Many elderly have a poor immune response to vaccines and remain very vulnerable even though fully vaccinated and boosted. Targeting Tollovid to this group needs to be a high priority. This demographic group gets first priority to vaccines. It seems to make sense that this group would also be the main focus of any marketing campaign for Tollovid.
I agree with your choice of influencers. Someone from West Palm Beach would be great and maybe someone from the Villages...perhaps not quite as rich, but equally concerned about their remaining longevity.
Thanks for your insightful response. I think there are many who will agree with your comment that "CCR5 "antagonist" is a huge--I mean HUGE field."
Shorter clips (topic specific) taken from the video:
Here's the Press Release about the video: "Todos Medical CEO Discusses Long COVID Economic Impact with Moneta Advisory Managing Partner Marc LoPresti"
https://investor.todosmedical.com/news-events/press-releases/detail/225/todos-medical-ceo-discusses-long-covid-economic-impact-with
Thanks, I wondered what the edits were.
Glad it's back up!
Interesting...about the video: "This video has been removed by the uploader."
Did they get too far in front of their headlights?
I agree, but just for clarification, the discussion about CCR5 dealt with Tollovir, not Tollovid.
Todos influencers like Kingcarlx need to let their followers know about the availability of this new video:
Agree with the good news in the video. I'd love to hear from our doctors about their take on the video...arpemd and misiu143.
Thanks for your response; that is the first I've heard it mentioned as well. Maybe covid is just the tip of the iceberg of potential uses for Tollovir.
I'm curious how others react to the discussion about CCR5 that starts about 19 minutes in. The discussion is about Tollovir and how it improves the immune system but Gerald frames the discussion around fighting cancers and how that would also help to fight viruses. Could this imply that Tollovir might eventually be used to help fight various forms of cancer because it boosts the immune system?
Excellent presentation...encourage all investors to view.
Video of Gerald at NASDAQ Discussing Covid/ Long Covid and Todos:
"Todos Medical CEO Discusses Long COVID Economic Impact with Moneta Advisory Partner Marc LoPresti"
I found it deceptive because it was a "Press Release"; "Long COVID Companies Cornering the Market - Published: Sept. 7, 2022 at 5:07 a.m. ET." The article starts off with a broad discussion of the various companies involved in the covid challenges but quickly narrows the discussion to Todos. It is a bit of a leap to think that Todos is "cornering the market" at the present time. You are right that the disclaimers portion of the article spelled out the relationship with Todos...but how many people really take the time to read the disclaimers?
GM, advertising can be somewhat of a thorny issue. I don't think many investors are opposed to advertising to market the company's goods and services. There are some excellent, professional videos that Todos has made featuring the benefits of Tollovid. My only concern with them is that they have had no national exposure...perhaps some exposure in a few selected areas. Some of us do have issues with what I consider to be deceptive advertising. To read a glowing article by a "reporter" about Todos only to realize in the fine print that it was a paid piece (not real reporting) is a little disconcerting. Todos definitely needs to market its products and services and there are a myriad of ways to do it without being deceptive.
From the last paragraph of the article: "CGR is compensated one thousand eight hundred dollars monthly via wire transfer by Todos Medical to produce and syndicate content related to TOMDF. "
Troubling article today in Reuters about the link between long-covid and depression and suicide:
Quote from article: "An analysis for Reuters conducted by Seattle-based health data firm Truveta showed that patients with long COVID were nearly twice as likely to receive a first-time antidepressant prescription within 90 days of their initial COVID diagnosis compared with people diagnosed with COVID alone."
https://www.reuters.com/business/healthcare-pharmaceuticals/long-covids-link-suicide-scientists-warn-hidden-crisis-2022-09-08/
3For3 sale extended one day:
mytollovid
@mytollovid
We’ve extended our "3for3" sale for ONE MORE DAY! ?? If you haven't already made your purchase, today is your last chance to catch the #sale — Get 3 bottles of #Tollovid for only $300! Sale ends TONIGHT at 11:59pm. Use code 3FOR3 at checkout.
https://bit.ly/3KwtX6C
GC post this morning...promising development.
Gerald Commissiong
@G_Commish
·$TOMDF #Tollovid sales 10x last weekend for same 3 day period! Campaign started off well, now we add more meat to the marketing bone. #NFL home opener coming. You can’t win being on the sideline. #stayinthegame with Tollovid. Big news coming
Just saw this Twitter post by Gerald::
$TOMDF - pharmacies getting ready COVID+MonkeyPox dual screening coming for school outbreaks in months ahead. COVID At-Home COVID PCR testing will also be huge. Marketing push coming for consumers of antigen (COVID PCR saliva 10/25/50 packs 36h TAT) & schools (MPX +COVID saliva).
8:03 PM · Sep 5, 2022
·Twitter for iPhone
Thanks JFB. Lots of activity!
Thanks for your response. I'll be glad to provide the DOJ anything they might need. I had a couple long interviews (under oath) with the DOJ, SEC, Postal Service, Prosecuting Attorney, FBI, and others as the government was preparing for trial. I sent them information from my lengthy contemporaneous notes that I took subsequent to my "VIP" tour of Arrayit on Oct 3, 2019. They asked me to testify for the prosecution; I agreed and subsequently received a subpoena. They never needed to call me to testify probably because they had so much written documentation, and numerous witnesses in the San Jose area. I live 2500 miles away.
Well I guess we received some closure on this long sad saga. I do feel some satisfaction that the justice system worked, although it took a long time and sentencing is still a long way off. I'm a little disappointed that I wasn't called to testify, having received a subpoena back in July. As one of the larger bag-holders I still have 13,786,738 shares that I'm willing to sell really cheap. My E-Trade account says they are worth $13.79. That's a far cry from well over $2 million (briefly) a few years ago. I wonder if I can still get a paper certificate.
I don't disagree with you about marketing to younger people. I just think priority needs to given to the audiences that need, and can benefit the most from Tollovid. Todos has made some very effective marketing videos about Tollovid and there is great information on the mytollovid.com site. But, I've yet to see one of these videos on national media. I had great expectations that the pre-Super Bowl marketing exposure would have parlayed into something greater...sadly, I don't think there was much bang for the buck.
I hope it works, but I question the rationale for having an influencer whose primary audience's demographics are people who are young who often consider themselves invincible. I would hope that there is an effort to target the older and more vulnerable population who really need Tollovid.
Recent Proactive video...GC discussing Monkeypox testing capabilities
Proactive Video on new leased space in Texas...from yesterday: